Filter
3336
Text search:
Vaccines
Featured
Recommendations
354
New Publications
772
Language
Document type
No document type
1349
Studies & Reports
627
Guidelines
531
Fact sheets
207
Strategic & Response Plan
192
Manuals
177
Situation Updates
65
Training Material
58
Resource Platforms
46
Videos
39
Infographics
19
Brochures
16
Online Courses
10
Countries / Regions
Global
196
India
106
Kenya
82
Liberia
69
Latin America and the Carribbean
67
Congo, Democratic Republic of
65
Nigeria
64
Sierra Leone
62
Africa
62
Uganda
60
South Africa
58
Ethiopia
53
Nepal
50
Western and Central Europe
45
Syria
41
Brazil
40
Ghana
35
Rwanda
35
Ukraine
33
Malawi
32
Zambia
31
Philippines
29
West and Central Africa
29
Russia
29
Bangladesh
28
East and Southern Africa
28
Middle East and North Africa
27
Guinea
26
Namibia
26
Tanzania
25
Zimbabwe
23
Haiti
22
South Sudan
22
Germany
22
South–East Asia Region
21
Myanmar / Burma
20
Venezuela
19
Senegal
17
Mozambique
17
Lesotho
16
Yemen
16
Eastern Europe
16
Cameroon
15
Pakistan
15
Burkina Faso
14
Cambodia
13
Asia
13
Botswana
12
Eastern Europe and Central Asia
12
Indonesia
11
Afghanistan
9
Central African Republic
9
Western Pacific Region
9
Argentina
8
Colombia
8
Madagascar
8
Chile
8
Paraguay
8
Niger
7
Lebanon
7
China
7
Sudan
7
Somalia
6
Benin
6
Eswatini/ Swaziland
6
Burundi
6
Mali
5
Peru
5
Moldova
5
Vietnam
5
Côte d’Ivoire / Ivory Coast
4
USA
4
Togo
4
Iraq
4
Jordan
4
Turkey
4
Chad
4
Bolivia
4
United Kingdom
4
Guinea-Bissau
3
Ecuador
3
El Salvador
3
Angola
3
Mexico
3
Albania
3
Laos
3
Congo-Brazzaville
3
Iran
3
France
3
Saudi Arabia
2
Thailand
2
Papua New Guinea
2
Nicaragua
2
Sri Lanka
2
Fiji
2
Bulgaria
2
Spain
2
Morocco
1
Egypt
1
Switzerland
1
Hungary
1
Honduras
1
Libya
1
Guatemala
1
Solomon Islands
1
Bhutan
1
Poland
1
Palestine
1
Southern Africa
1
Timor Leste/ East Timor
1
Tajikistan
1
Romania
1
Slovakia
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
North America
1
Gabon
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Japan
1
Denmark
1
Maldives
1
Tunisia
1
Portugal
1
South Korea
1
Belarus
1
French Guyana
1
Authors & Publishers
Publication Years
Category
Countries
1207
Clinical Guidelines
269
Women & Child Health
161
Public Health
156
Key Resources
131
Pharmacy & Technologies
47
Capacity Building
30
Annual Report MEDBOX
2
Toolboxes
COVID-19
736
AMR
156
Ebola & Marburg
155
HIV
126
TB
120
Rapid Response
116
NTDs
107
Pharmacy
93
Health Financing Toolbox
90
Global Health Education
78
Conflict
77
Planetary Health
69
Malaria
61
Refugee
58
Cholera
57
Caregiver
56
Polio
51
2.0 Rapid Response
50
Mental Health
46
Natural Hazards
26
Zika
23
NCDs
19
Disability
18
Specific Hazards
12
Typhoon
2
Since the release of the first volume in May 2020, the COVID-19 pandemic has continued to rage around the world. By mid-March, 2021, countries around the globe had reported over 123 million cases—a nearly five-fold increase since this report’s previous volume—and over 2.7 million deaths attrib
...
Diarrhea is one of the world’s leading causes of child illness and death, and rotavirus is the most common cause of severe diarrhea. Yet it can be prevented and treated. There is a vaccine. And while hundreds of thousands of children in India will gain access to rotavirus
...
Version 2.3 , 21 April 2022. The CVIC tool supports credible COVID-19 vaccination costing to facilitate a dialogue with stakeholders, while maintaining sensitivity to protect essential health services.
The CVIC tool provides a structured and comprehensive estimation of incremental operational and
...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de
...
As of December 2018, CEPI has secured more than USD $747million towards its USD $1billion funding target, with financial support provided by the Bill & Melinda Gates Foundation, the Wellcome Trust, the European Commission, and the governments of Australia, Belgium, Canada, Germany, Japan, Norway, an
...
Chikungunya virus (CHIKV) is a re-emerging mosquito borne alphavirus responsible
for the recent outbreak in the Americas. Immunologically naïve population in the Americas favors the spread of epidemics. Chikungunya fever is characterized by an abrupt febrile illness, polyarthralgia and maculopapul
...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var
...
Overview
The aim of this guide is to support national immunization programme managers and others responsible for implementing human rabies vaccine programmes to:
inform policy discussions and operational planning for introducing or expanding rabies post-exposure prophylaxis (PEP) into a nationa
...
This research report offers community perceptions of COVID-19 from migrants, refugees, host communities and indigenous populations in nine countries in the Americas: Argentina, Brazil, Bolivia, Colombia, Guatemala, Nicaragua, Jamaica, Panama and Trinidad and Tobago.
It reveals the myriad impacts
...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re
...
Covid-19 Test to Treat Guidelines
recommended
n response to the outbreak, the Africa Centres for Disease Control and Prevention (Africa CDC) has been supporting African Union Member States in responding to the COVID-19 pandemic through a variety of interventions such as non-pharmaceutical interventions, quarantine, testing, isolation, contact t
...
Visit the Ebola Outbreak page on NEJM.org for a collection of articles and other resources, including powerful, personal essays with first-hand reporting from caregivers in the field, an interactive graphic with information on past and present Ebola outbreaks, and an audio interview with NIAID Direc
...
Updted Sept.2021
Hesperian stated producing COVID-19 related materials beginning with, English and Spanish versions, even as they were transitioning to remote work. They understood that accurate information from a credible source circulated as early as possible would be critical. Faster than had ev
...
n recent decades, a significant improvement in people’s general health conditions has occurred, leading to an increase in life expectancy at birth in most countries in the Region of the Americas. This progress has been the result of both health technology advances – antibiotics,
...
Just 15 weeks into 2019, more measles outbreaks have been declared in South Sudan than occurred in all of 2018. As of Wednesday, 10 April, there had been 11 active outbreaks and four deaths had been confirmed. Another two deaths are suspected cases of measles. Earlier this year a campaign to vaccina
...
Revised COVID-19 Testing Strategy
recommended
Second edition. June 2022. This revised guidance recommends that access to COVID-19 testing is decentralized as far as possible and made available at health facilities, and through the use of self tests to enable access to care and the mitigation of transmission. Testing should be prioritized for hi
...
This document is intended for countries, foundations, and civil society. It provides a consolidated overview of the Access to COVID-19 Tools (ACT) Accelerator, its goals, and the investments that partners have calculated are required to carry out its mission. Emergency responses are dynamic by natur
...
For 50 SAM children with medical complications and for a paediatric ward of 10-15 beds for 3 months
The PED/SAM kit is especially designed to provide medicines, renewables and equipment suitable for children and to treat the common childhood illness including severe acute malnutrition with medica
...
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac
...
